Role of prefrontal cortical calcium-independent phospholipase A2 in antinociceptive effect of the norepinephrine reuptake inhibitor antidepresssant maprotiline. (6th January 2017)

• Record Type: Journal Article
• Authors: Chew, Wee-Siong; Shalini, Suku-Maran; Torta, Federico; Wenk, Markus R.; Stohler, Christian; Yeo, Jin-Fei; Herr, Deron R.; Ong, Wei-Yi
• Is Part Of: Neuroscience. Volume 340(2017)
• Page Start: 91
• Page End: 100
• Publication Date: 2017-01-06
• Subjects: DHA docosahexaenoic acid -- EDTA ethylenediaminetetraacetic acid -- EPA eicosapentaenoic acid -- iPLA2 calcium-independent phospholipase A2 -- MRM Multiple Reaction Monitoring -- NRI noradrenaline reuptake inhibitor -- PAG periaqueductal gray -- PFC prefrontal cortex -- PVDF polyvinylidene difluoride; noradrenaline -- prefrontal cortex -- antinociception -- lipid mediators -- pain; Neurochemistry -- Periodicals; Neurophysiology -- Periodicals; Neurology -- Periodicals; Neurochimie -- Périodiques; Neurophysiologie -- Périodiques; Neurochemistry; Neurophysiology; Electronic journals; Periodicals; Electronic journals; 612.8
• DOI: 10.1016/j.neuroscience.2016.10.037
• Languages: English
• ISSNs: 0306-4522

Abstract

Highlights: Treatment of mice with maprotiline resulted in modulation of inflammatory facial pain. This effect was abolished by prefrontal cortical knockdown of iPLA2. Results indicate a role of prefrontal cortical iPLA2 in antinociception. Abstract: The prefrontal cortex is essential for executive functions such as decision-making and planning. There is also accumulating evidence that it is important for the modulation of pain. In this study, we investigated a possible role of prefrontal cortical calcium-independent phospholipase A2 (iPLA2 ) in antinociception induced by the norepinephrine reuptake inhibitor (NRI) and tetracyclic (tricyclic) antidepressant, maprotiline. Intraperitoneal injections of maprotiline increased iPLA2 mRNA and protein expression in the prefrontal cortex. This treatment also reduced grooming responses to von-Frey hair stimulation of the face after facial carrageenan injection, indicating decreased sensitivity to pain. The antinociceptive effect of maprotiline was abrogated by iPLA2 antisense oligonucleotide injection to the prefrontal cortex, indicating a role of this enzyme in antinociception. In contrast, injection of iPLA2 antisense oligonucleotide to the somatosensory cortex did not reduce the antinociceptive effect of maprotiline. Lipidomic analysis of the prefrontal cortex showed decrease in phosphatidylcholine species, but increase in lysophosphatidylcholine species, indicating increased PLA2 activity, and release of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) after maprotiline treatment. Differences in sphingomyelin/ceramide were also detected. These changes were not observed in maprotiline-treated mice that received iPLA2 antisense oligonucleotide to the prefrontal cortex. Metabolites of DHA and EPA may help to strengthen a known supraspinal antinociceptive pathway from the prefrontal cortex to the periaqueductal gray. Together, results indicate a role of prefrontal cortical iPLA2 and its enzymatic products in the antinociceptive effect of maprotiline.